Molecular Partners Taps Healthcare M&A Veteran Clare Fisher for Board Seat
Molecular Partners nominates M&A veteran Clare Fisher to its board as 12-year member Steven Holtzman retires, signaling strategic emphasis on business development and partnerships.
MOLNONCbiotechAnnual General Meeting